Brief: BridgeBio Announces Agreement With U.S. Govt To Improve Affordability & Access To Critical Medicines
31/08/2026 20:49
BRIEF-BridgeBio Announces Agreement With U.S. Govt To Improve Affordability & Access To Critical Medicines Sept 1 (Reuters) - BridgeBio Pharma, Inc. BBIO.O:
BRIDGEBIO ANNOUNCES AGREEMENT WITH U.S. GOVERNMENT TO IMPROVE AFFORDABILITY AND ACCESS TO CRITICAL MEDICINES FOR AMERICANS
BRIDGEBIO PHARMA - TO EXPAND STATE MEDICAID ACCESS TO MARKETED MEDICINE VIA GENEROUS MODEL
BRIDGEBIO PHARMA - TO OFFER ATTRUBY VIA MEDICARE PART D WITHOUT FUTURE PRICING MANDATES
BRIDGEBIO PHARMA - AGREEMENT DOES NOT IMPACT FORGINGBRIDGES COPAY ASSISTANCE PROGRAM
BRIDGEBIO PHARMA - DOES NOT EXPECT FUTURE PRICING MANDATES; TERMS REMAIN CONFIDENTIAL
Source text: ID:nGNX7p6LNz
Further company coverage: BBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BridgeBio Pharma
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
BridgeBio rises on FDA priority review for dwarfism drug
Brief: Bridgebio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasia
Brief: Bbp-418 Demonstrates Potential To Be Disease Modifying Therapy, Restoring Cardiac And Disease Markers To Unaffected Levels